• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

具有核壳结构的紫杉醇-介孔二氧化硅纳米粒子对人肺癌细胞系A549的影响

Effect of Paclitaxel-Mesoporous Silica Nanoparticles with a Core-Shell Structure on the Human Lung Cancer Cell Line A549.

作者信息

Wang Tieliang, Liu Ying, Wu Chao

机构信息

Animal Husbandry and Veterinary Medicine School, Jinzhou Medical University, 40 Songpo Road, Linghe District, Jinzhou, Liaoning Province, 121000, China.

Pharmacy School, Jinzhou Medical University, 40 Songpo Road, Linghe District, Jinzhou, Liaoning Province, 121000, China.

出版信息

Nanoscale Res Lett. 2017 Dec;12(1):66. doi: 10.1186/s11671-017-1826-1. Epub 2017 Jan 23.

DOI:10.1186/s11671-017-1826-1
PMID:28116610
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5256628/
Abstract

A nanodrug delivery system of paclitaxel-mesoporous silica nanoparticles with a core-shell structure (PAC-csMSN) was used to increase the dissolution of paclitaxel (PAC) and improve its treatment of lung cancer. PAC was loaded into the core-shell mesoporous silica nanoparticles (csMSN) by the adsorption equilibrium method and was in an amorphous state in terms of its mesoporous structure. In vitro and in vivo studies showed that csMSN increased the dissolution rate of PAC and improved its lung absorption. The area under concentration-time curve (AUC) value of PAC-csMSN used for pulmonary delivery in rabbits was 2.678-fold higher than that obtained with the PAC. After continuous administration for 3 days, a lung biopsy showed no signs of inflammation. Cell apoptosis results obtained by flow cytometry indicated that PAC-csMSN was more potent than pure PAC in promoting cell apoptosis. An absorption investigation of PAC-csMSN in A549 cells was carried out by transmission electron microscopy (TEM) and laser scanning confocal microscopy (LSCM). The obtained results indicated that the cellular uptake was time-dependent and csMSN was uptaken into the cytoplasm. All these results demonstrate that csMSN have the potential to achieve pulmonary inhalation administration of poorly water-soluble drugs for the treatment of lung cancer.

摘要

采用具有核壳结构的紫杉醇-介孔二氧化硅纳米粒(PAC-csMSN)纳米药物递送系统来提高紫杉醇(PAC)的溶解度,并改善其对肺癌的治疗效果。通过吸附平衡法将PAC负载到核壳介孔二氧化硅纳米粒(csMSN)中,就其介孔结构而言,PAC呈无定形状态。体外和体内研究表明,csMSN提高了PAC的溶解速率并改善了其肺部吸收。用于兔肺部给药的PAC-csMSN的浓度-时间曲线下面积(AUC)值比PAC的AUC值高2.678倍。连续给药3天后,肺活检显示无炎症迹象。通过流式细胞术获得的细胞凋亡结果表明,PAC-csMSN在促进细胞凋亡方面比纯PAC更有效。通过透射电子显微镜(TEM)和激光扫描共聚焦显微镜(LSCM)对A549细胞中PAC-csMSN的吸收进行了研究。所得结果表明,细胞摄取具有时间依赖性,且csMSN被摄取到细胞质中。所有这些结果表明,csMSN有潜力实现难溶性药物的肺部吸入给药以治疗肺癌。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3319/5256628/10883c46247f/11671_2017_1826_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3319/5256628/8cfd1fd95d64/11671_2017_1826_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3319/5256628/2665127eac9f/11671_2017_1826_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3319/5256628/deec9194a950/11671_2017_1826_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3319/5256628/10883c46247f/11671_2017_1826_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3319/5256628/8cfd1fd95d64/11671_2017_1826_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3319/5256628/2665127eac9f/11671_2017_1826_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3319/5256628/deec9194a950/11671_2017_1826_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3319/5256628/10883c46247f/11671_2017_1826_Fig6_HTML.jpg

相似文献

1
Effect of Paclitaxel-Mesoporous Silica Nanoparticles with a Core-Shell Structure on the Human Lung Cancer Cell Line A549.具有核壳结构的紫杉醇-介孔二氧化硅纳米粒子对人肺癌细胞系A549的影响
Nanoscale Res Lett. 2017 Dec;12(1):66. doi: 10.1186/s11671-017-1826-1. Epub 2017 Jan 23.
2
Targeted Delivery of Paclitaxel in Liver Cancer Using Hyaluronic Acid Functionalized Mesoporous Hollow Alumina Nanoparticles.基于透明质酸功能化介孔中空氧化铝纳米粒子的肝癌靶向载紫杉醇给药系统。
Biomed Res Int. 2019 Apr 15;2019:2928507. doi: 10.1155/2019/2928507. eCollection 2019.
3
Synthesis of novel core-shell structured dual-mesoporous silica nanospheres and their application for enhancing the dissolution rate of poorly water-soluble drugs.新型核壳结构双介孔二氧化硅纳米球的合成及其在提高难溶性药物溶出速率中的应用。
Mater Sci Eng C Mater Biol Appl. 2014 Nov;44:262-7. doi: 10.1016/j.msec.2014.08.040. Epub 2014 Aug 21.
4
Core-shell microcapsules of solid lipid nanoparticles and mesoporous silica for enhanced oral delivery of curcumin.用于增强姜黄素口服递送的固体脂质纳米颗粒和介孔二氧化硅核壳微胶囊。
Colloids Surf B Biointerfaces. 2016 Apr 1;140:161-168. doi: 10.1016/j.colsurfb.2015.12.040. Epub 2015 Dec 28.
5
Mesoporous silica nanoparticles for increasing the oral bioavailability and permeation of poorly water soluble drugs.介孔硅纳米粒提高难溶性药物口服生物利用度和渗透的研究
Mol Pharm. 2012 Mar 5;9(3):505-13. doi: 10.1021/mp200287c. Epub 2012 Feb 1.
6
[Targeted killing of CD133 lung cancer stem cells using paclitaxel-loaded PLGA-PEG nanoparticles with CD133 aptamers].使用负载紫杉醇且带有CD133适配体的聚乳酸-羟基乙酸共聚物-聚乙二醇纳米颗粒靶向杀伤CD133肺癌干细胞
Nan Fang Yi Ke Da Xue Xue Bao. 2022 Jan 20;42(1):26-35. doi: 10.12122/j.issn.1673-4254.2022.01.03.
7
Lipid-coated hollow mesoporous silica nanospheres for co-delivery of doxorubicin and paclitaxel: Preparation, sustained release, cellular uptake and pharmacokinetics.用于阿霉素和紫杉醇共递送的脂质包被中空介孔二氧化硅纳米球:制备、缓释、细胞摄取及药代动力学
Mater Sci Eng C Mater Biol Appl. 2017 Feb 1;71:835-843. doi: 10.1016/j.msec.2016.10.081. Epub 2016 Nov 1.
8
Development of a tin oxide carrier with mesoporous structure for improving the dissolution rate and oral relative bioavailability of fenofibrate.一种具有介孔结构的氧化锡载体的研发,用于提高非诺贝特的溶出速率和口服相对生物利用度。
Drug Des Devel Ther. 2018 Jul 10;12:2129-2138. doi: 10.2147/DDDT.S166989. eCollection 2018.
9
Novel scheme for rapid synthesis of hollow mesoporous silica nanoparticles (HMSNs) and their application as an efficient delivery carrier for oral bioavailability improvement of poorly water-soluble BCS type II drugs.新型快速合成中空介孔硅纳米粒子(HMSNs)的方案及其作为改善难溶性 BCS Ⅱ类药物口服生物利用度的有效递送载体的应用。
Colloids Surf B Biointerfaces. 2019 Apr 1;176:185-193. doi: 10.1016/j.colsurfb.2019.01.004. Epub 2019 Jan 2.
10
In Vitro and In Vivo Evaluation of Core-Shell Mesoporous Silica as a Promising Water-Insoluble Drug Delivery System: Improving the Dissolution Rate and Bioavailability of Celecoxib With Needle-Like Crystallinity.体外和体内评价核壳介孔二氧化硅作为有前途的水不溶性药物传递系统:提高塞来昔布的溶解速率和生物利用度与针状结晶度。
J Pharm Sci. 2019 Oct;108(10):3225-3232. doi: 10.1016/j.xphs.2019.06.011. Epub 2019 Jun 18.

引用本文的文献

1
How Key Alterations of Mesoporous Silica Nanoparticles Affect Anti-Lung Cancer Therapy? A Comprehensive Review of the Literature.介孔二氧化硅纳米粒子的关键改变如何影响抗肺癌治疗?文献综述。
Int J Nanomedicine. 2023 Sep 25;18:5473-5493. doi: 10.2147/IJN.S426120. eCollection 2023.
2
Fabrication of a Dual-Targeted Liposome-Coated Mesoporous Silica Core-Shell Nanoassembly for Targeted Cancer Therapy.用于靶向癌症治疗的双靶向脂质体包被介孔二氧化硅核壳纳米组装体的制备
ACS Omega. 2023 Sep 12;8(38):34481-34498. doi: 10.1021/acsomega.3c02901. eCollection 2023 Sep 26.
3
Preclinical Assessment of ADAM9-Responsive Mesoporous Silica Nanoparticles for the Treatment of Pancreatic Cancer.

本文引用的文献

1
ZnO nanoparticle tracking from uptake to genotoxic damage in human colon carcinoma cells.从人结肠癌细胞摄取到遗传毒性损伤的氧化锌纳米颗粒追踪
Toxicol In Vitro. 2016 Sep;35:169-79. doi: 10.1016/j.tiv.2016.06.005. Epub 2016 Jun 16.
2
Enhanced cellular uptake and phototoxicity of Verteporfin-conjugated gold nanoparticles as theranostic nanocarriers for targeted photodynamic therapy and imaging of cancers.作为用于癌症靶向光动力疗法和成像的治疗诊断纳米载体,维替泊芬共轭金纳米颗粒的细胞摄取增强及光毒性研究
Mater Sci Eng C Mater Biol Appl. 2016 Oct 1;67:611-622. doi: 10.1016/j.msec.2016.05.047. Epub 2016 May 16.
3
Hollow mesoporous silica as a high drug loading carrier for regulation insoluble drug release.
ADAM9 响应性介孔二氧化硅纳米颗粒治疗胰腺癌的临床前评估。
Int J Mol Sci. 2023 Jun 27;24(13):10704. doi: 10.3390/ijms241310704.
4
The emergence of nanoporous materials in lung cancer therapy.纳米多孔材料在肺癌治疗中的出现。
Sci Technol Adv Mater. 2022 Jul 20;23(1):225-274. doi: 10.1080/14686996.2022.2052181. eCollection 2022.
5
Activatable "Matryoshka" nanosystem delivery NgBR siRNA and control drug release for stepwise therapy and evaluate drug resistance cancer.可激活的“套娃”纳米系统递送NgBR小干扰RNA并控制药物释放以进行逐步治疗并评估耐药性癌症。
Mater Today Bio. 2022 Mar 19;14:100245. doi: 10.1016/j.mtbio.2022.100245. eCollection 2022 Mar.
6
Advanced Nanoparticle-Based Drug Delivery Systems and Their Cellular Evaluation for Non-Small Cell Lung Cancer Treatment.基于高级纳米颗粒的药物递送系统及其在非小细胞肺癌治疗中的细胞评估
Cancers (Basel). 2021 Jul 15;13(14):3539. doi: 10.3390/cancers13143539.
7
Soft and Condensed Nanoparticles and Nanoformulations for Cancer Drug Delivery and Repurpose.用于癌症药物递送及重新利用的柔软和致密纳米颗粒与纳米制剂
Adv Ther (Weinh). 2020 Jan;3(1). doi: 10.1002/adtp.201900102. Epub 2019 Oct 16.
8
ADAM9-Responsive Mesoporous Silica Nanoparticles for Targeted Drug Delivery in Pancreatic Cancer.用于胰腺癌靶向给药的ADAM9响应性介孔二氧化硅纳米颗粒
Cancers (Basel). 2021 Jul 1;13(13):3321. doi: 10.3390/cancers13133321.
9
Targeted Nanotherapeutics for Respiratory Diseases: Cancer, Fibrosis, and Coronavirus.用于呼吸系统疾病的靶向纳米疗法:癌症、纤维化和冠状病毒。
Adv Ther (Weinh). 2021 Feb;4(2):2000203. doi: 10.1002/adtp.202000203. Epub 2020 Oct 13.
10
I-Traced PLGA-Lipid Nanoparticles as Drug Delivery Carriers for the Targeted Chemotherapeutic Treatment of Melanoma.I-追踪聚乳酸-羟基乙酸共聚物-脂质纳米颗粒作为黑色素瘤靶向化疗治疗的药物递送载体
Nanoscale Res Lett. 2017 Dec;12(1):365. doi: 10.1186/s11671-017-2140-7. Epub 2017 May 19.
中空介孔硅作为一种高载药量的载体,用于调节难溶性药物的释放。
Int J Pharm. 2016 Aug 20;510(1):184-94. doi: 10.1016/j.ijpharm.2016.05.067. Epub 2016 Jun 2.
4
Naringenin-loaded solid lipid nanoparticles: preparation, controlled delivery, cellular uptake, and pulmonary pharmacokinetics.载柚皮素固体脂质纳米粒:制备、控释、细胞摄取及肺部药代动力学
Drug Des Devel Ther. 2016 Mar 1;10:911-25. doi: 10.2147/DDDT.S97738. eCollection 2016.
5
Curcumin-loaded silica-based mesoporous materials: Synthesis, characterization and cytotoxic properties against cancer cells.载姜黄素的硅基介孔材料:合成、表征及对癌细胞的细胞毒性。
Mater Sci Eng C Mater Biol Appl. 2016 Jun;63:393-410. doi: 10.1016/j.msec.2016.03.011. Epub 2016 Mar 4.
6
Paclitaxel molecularly imprinted polymer-PEG-folate nanoparticles for targeting anticancer delivery: Characterization and cellular cytotoxicity.用于靶向抗癌递送的紫杉醇分子印迹聚合物-聚乙二醇-叶酸纳米颗粒:表征与细胞毒性
Mater Sci Eng C Mater Biol Appl. 2016 May;62:626-33. doi: 10.1016/j.msec.2016.01.059. Epub 2016 Jan 26.
7
PEG-derivatized octacosanol as micellar carrier for paclitaxel delivery.聚乙二醇衍生化二十八烷醇作为紫杉醇递送的胶束载体。
Int J Pharm. 2016 Mar 16;500(1-2):345-59. doi: 10.1016/j.ijpharm.2016.01.030. Epub 2016 Jan 18.
8
Superparamagnetic iron-oxide nanoparticles mPEG350- and mPEG2000-coated: cell uptake and biocompatibility evaluation.超顺磁性氧化铁纳米颗粒 mPEG350- 和 mPEG2000 涂层:细胞摄取和生物相容性评价。
Nanomedicine. 2016 May;12(4):909-919. doi: 10.1016/j.nano.2015.12.371. Epub 2016 Jan 6.
9
Development of novel core-shell dual-mesoporous silica nanoparticles for the production of high bioavailable controlled-release fenofibrate tablets.新型核壳双介孔二氧化硅纳米颗粒用于制备高生物利用度的非诺贝特控释片的研发。
Drug Dev Ind Pharm. 2016;42(2):199-208. doi: 10.3109/03639045.2015.1039018. Epub 2015 Jun 26.
10
LFC131 peptide-conjugated polymeric nanoparticles for the effective delivery of docetaxel in CXCR4 overexpressed lung cancer cells.LFC131肽缀合的聚合物纳米颗粒用于在CXCR4过表达的肺癌细胞中有效递送多西他赛。
Colloids Surf B Biointerfaces. 2015 Sep 1;133:43-50. doi: 10.1016/j.colsurfb.2015.05.030. Epub 2015 May 23.